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Abstract 
Drug addiction is a major psychiatric disorder with a neurobiological base that is still 
insufficiently understood. Initially, non-addicted, controlled drug consumption and 
drug instrumentalization are established. They comprise highly systematic 
behaviours acquired by learning and the establishment of drug memories. 
Ca2+/calmodulin-dependent protein kinases (CaMKs) are important Ca2+-sensors 
translating glutamatergic activation into synaptic plasticity during learning and 
memory formation. Here we review the role of CaMKs in the establishment of drug-
related behaviours in animal models and in humans. Converging evidence shows 
now that CaMKs are a crucial mechanism of how addictive drugs induce synaptic 
plasticity and establish various types of drug memories. Thereby, CaMKs are not only 
molecular relays for glutamatergic activity; they also directly control dopaminergic 
and serotonergic activity in the mesolimbic reward system. They can now be 
considered as major molecular pathways translating normal memory formation into 
establishment of drug memories and possibly transition to drug addiction. 
Keywords: Ca2+/calmodulin-dependent protein kinase, drug dependence, addiction, 
psychostimulants, alcohol, opioids 
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Drug Use and Addiction 
Drug addiction is a major psychiatric disorder for which only limited therapies are 
currently available [1,2]. A striking criterion for drug abuse and addiction is that it 
severely threatens one’s own and others well-being and health. As such, there is a 
persistent need to treat drug addiction effectively, and ideally reverse the behavioural 
repertoire of an affected individual back to normal. 
An important feature of drug addiction is that it develops from a behavioural 
repertoire, which is considered to be normal in many societies of the world: the 
controlled consumption and instrumentalization of psychoactive drugs [3,4]. 
Establishing and maintaining controlled drug consumption is based on systematic 
learning and memory retrieval of distinct behaviours, related to drug seeking, 
preparation, and consumption in a specific context [5,6]. Thereby, information is 
encoded within different behavioural systems, which can be summarized as “drug 
memories” [5,7-9] (Box 1). It is believed that an intensification of these memories 
together with a loss of impulse control (compulsivity) is responsible for the transition 
from controlled drug use to addiction [10-12]. Understanding how these drug 
memories are established and how they may take control over a normal behavioural 
repertoire should, therefore, allow to improve the prevention of addiction and to 
develop new and more effective treatments [13]. 
 
From Memories to Drug Memories 
It was suggested that anatomical pathways, micro-morphological adaptations, as well 
as molecular mechanisms in the brain, overlap between normal learning and memory 
and drug memories [14-16]. A crucial player for memory formation in the brain is the 
glutamatergic system and its plasticity based on experience [17]. Addiction research 
considered glutamate as an important mediator during the establishment of drug use, 
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but also during escalation of consumption and addictive states [18]. The most 
abundant excitatory neurotransmitter in the brain, glutamate, activates α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and N-methyl-D-aspartate 
(NMDA) receptors to generate intracellular Ca2+-transients. This cascade is pivotal 
for long-term potentiation (LTP) and subsequent alterations in gene expression that 
are the base for morphological adaptations at the synapse during learning [17]. A 
major pathway for this is the Ca2+ activation of calmodulin (CaM) and subsequent 
activation of Ca2+/CaM dependent kinases (CaMKs). Here, we review how this 
memory pathway controls the establishment of drug-addiction related behaviours. In 
order to determine whether this role is drug specific or works as a common principle, 
CaMK function for different drug classes is compared. 
 
Molecular Neurobiology of CaMKs 
Calcium signalling through NMDA receptors is a fundamental step for inducing long-
lasting synaptic plasticity, which is thought to be a key mechanism underlying 
learning and memory [19].  Due to high levels of CaM at the synapse, Ca2+ influx 
through NMDA receptors leads to formation of Ca2+/CaM complexes [20], which 
activate CaMKs. Among the CaMKs, CaMKII has received most of the attention since 
this protein is very abundant in the brain [21] and because this multifunctional kinase 
has remarkable biochemical properties [22]. CaMKII is a holoenzyme that consists of 
12 subunits [23]. CaMKII and CaMKII are the most abundant CaMKII subunits in 
the brain [21]. While CaMKII is expressed only in glutamatergic neurons [24], 
CaMKII occurs in inhibitory [25] and in excitatory neurons [26]. CaMKII, but not 
CaMKII, binds to F-actin. This localizes the CaMKII holoenzyme. The binding to F-
actin is relieved by binding of Ca2+/CaM [22]. The dissociation of CaMKII from F-actin 
5 
is thought to regulate actin polymerization that shapes synapse morphology [27]. 
CaMKII, but not CaMKII activity is critical for CaMKII function [26]. CaMKII 
activity is primarily regulated by autophosphorylation at threonine-286 (T286), which 
results from an intersubunit kinase reaction within the holoenzyme. T286-
autophosphorylation switches the kinase from Ca2+/CaM-dependence to 
independence [28]. Currently, it is thought that T286-autophosphorylated CaMKII 
prolongs CaMKII activity at the synapse after the Ca2+ stimulus [29]. This leads to 
glutamate receptor trafficking to the postsynaptic density, resulting in enhanced 
synaptic transmission [20]. Moreover, CaMKII activity is also regulated by ‘inhibitory’ 
autophosphorylation at T305/306 [30], endogenous CaMKII inhibitor proteins [31], 
and phosphatase activity [32]. Given its somewhat outstanding role in learning and 
memory, most addiction-related research has focused on CaMKII, which also puts it 
into the focus of this review.  
In addition to regulation of CaMKII, Ca2+/CaM also activates other members of the 
CaM kinase cascade. CaMKI, CaMKIV and Ca2+/CaM kinase kinase (CaMKK) 
belong to this kinase cascade. CaMKK phosphorylates CaMKI and CaMKIV to 
activate these kinases [33]. This kinase cascade may have proof reading character in 
that only ‘real’ strong Ca2+ signals can induce it. Once activated, CaMKI and CaMKIV 
regulate gene transcription in the nucleus and local protein synthesis, which are 
needed for long-lasting synaptic plasticity [22]. 
CaMKs and Their Role in Memories 
Mouse molecular genetic manipulations have now established that the CaMKs have 
a fundamental function in hippocampus-dependent learning and memory [22,34]. 
Loss of CaMKII and CaMKII expression impairs contextual and spatial memory 
6 
formation [26,34,35]. A point mutation that prevents the T286-autophosphorylation of 
CaMKII severely impairs spatial and contextual memory formation [36,37]. In 
addition to having a role in memory formation, the T286-autophosphorylation has 
also been suggested to mediate memory storage and maintenance [20]. However, in 
the absence of T286-autophosphorylation, hippocampus-dependent long-term 
memory can still be formed after massed training [38]. Thus, CaMKII activity appears 
to be primarily important for the acceleration of memory formation but not for memory 
storage per se [39]. 
Members of the CaMK cascade are important for consolidation of hippocampus-
dependent long-term memory. However, each member of this kinase cascade 
appears to have a specific role in consolidation rather than being important for all 
types of hippocampal memory consolidations. Accordingly, CaMKIV is required for 
consolidation of contextual, but not spatial memory [40,41]. Further, the -isoform of 
CaMKK is likely to contribute to consolidation of spatial memory and memory of the 
delay version of the social transmission of food preferences task [42]. Interestingly, it 
is only required for this long-term memory formation in males, but not in females [43], 
thus, suggesting memory consolidation mechanisms differ between the sexes [44]. 
Similarly, CaMKK is required for contextual, but not spatial, long-term memory 
formation in males, but not in females [45,46]. Genetic studies now support an 
important role of CaMKs also in human learning and memory (Box 2). 
CaMKs and Their Role in Drug Memories 
Distinct types of drug memories have been identified and grouped according to the 
system for normal memories (i.e. non-drug related memories) in humans (Box 1). 
Animal models of drug use and addiction, however, depict complex behaviours, 
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which normally involve several types of drug memories (Glossary) [47]. 
Neurobiological mechanisms may, therefore, overlap between single types of drug 
memories [5-8].    
 
Psychostimulants 
Psychostimulants drugs have common behavioural and subjective effects. They 
increase behavioural activity and arousal, and can also induce euphoria in humans. 
Drugs that share these effects include cocaine and amphetamine (AMPH) together 
with its derivatives [1]. An acute injection of cocaine [48] or AMPH [49] induces an 
increase in T286-phosphorylated CaMKII levels in the striatum of rats, but has no 
effect on total CaMKII levels (Figure 1). Chronic cocaine or AMPH administration 
and self-administration increases levels of CaMKII in the nucleus accumbens (NAc) 
shell, but not NAc core of rats. This effect is paralleled by phosphorylation of the 
GluA1 AMPA receptor subunit and persists several weeks after drug administration 
(Table 1) [50-52]. An increase in CaMKII activity leads to an upregulation of 
functional AMPA receptors [53] and receptor conductance [54]. After seven days of 
withdrawal from repeated cocaine administration, but not after fewer days, levels of 
CaMKII and phosphorylated CaMKII (pCaMKII) are increased in the NAc, prefrontal 
cortex (PFC) or dorsal striatum (DS). Both return to control levels several weeks after 
withdrawal [55-57]. The reinstatement of cocaine-seeking by a priming injection of 
cocaine induces an increase in pCaMKII in the NAc shell, but not in the NAc core of 
rats [58]. 
Locomotor Sensitization: Psychostimulant enhanced Ca2+-influx through AMPA, 
NMDA, and L-type Ca2+-channels leads to activation of CaM in dopaminergic 
neurons of the ventral tegmental area (VTA). Subsequent activation of CaMKII 
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enhances phosphorylation of various targets and promotes sensitization of 
hyperlocomotor responses in a context-dependent way [59] (Table 1, Glossary). 
CaMKII activation in the VTA, NAc, and hippocampus appears of crucial importance 
for locomotor sensitization to cocaine and AMPH [60-64]. The sensitization of the 
AMPH-induced locomotor activation is blunted in αCaMKII deficient mice [65]. 
Transient inhibition of CaMKII in the NAc shell reverses the increase in pGluA1 
levels and attenuates AMPH-induced locomotor sensitization [66]. αCaMKII 
autophosphorylation-deficient mice have preserved sensitization of the 
hyperlocomotor effects of cocaine [67]. Mice which lack CaMKIV in dopamine D1-
receptor expressing neurons do not sensitize to the hyperlocomotor effects of 
cocaine [68]. 
Conditioned place preference (CPP): CaMKII activation in the VTA, NAc, and 
hippocampus appears of crucial importance for CPP establishment after cocaine and 
AMPH treatment [61-64]. αCaMKII-deficient mice are not impaired in AMPH- or 
cocaine-induced CPP when only endpoints of the learning are considered [65]. 
However, αCaMKII autophosphorylation-deficient mice are significantly delayed in 
their ability to establish cocaine-induced CPP [67]. Mice with a striatum-specific 
autonomously active CaMKII show potentiated cocaine CPP after low, but not after 
high doses of cocaine [64]. Several studies identified the VTA-NAc axis as a crucial 
pathway of CaMKII action in the establishment of cocaine-induced synaptic plasticity 
and CPP [69,70]. Local injection of the CaMKII inhibitory peptide TatCN21 into the 
VTA blocks establishment of cocaine-CPP and cocaine-evoked depression of 
excitatory synaptic transmission in the NAc shell [70].  
Mice lacking CaMKIV in D1-receptor expressing neurons show enhanced 
establishment and reinstatement of cocaine-CPP [68]. However, reduced CaMKIV 
activity is also associated with enhanced social anxiety [71] and reduced fear 
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learning [41]. These findings suggest that CaMKIV may work as a resilience factor 
against cocaine addiction possibly by stabilizing emotional tone. 
Self-administration: The activation of CaMKII in the VTA, NAc, and hippocampus 
appears of crucial importance for self-administration of cocaine and AMPH [61-64]. 
Transient overexpression of CaMKII in the NAc shell increases not only pGluA1 
levels, but also AMPH self-administration in rats [72]. Transient inhibition of CaMKII 
in NAc shell reduces AMPH self-administration in sensitized rats [51,66]. Cocaine 
effects on αCaMKII-, but not CaMKII expression are suggested to be essential for 
the motivation to self-administer cocaine. αCaMKII expression correlates with break 
points during cocaine self-administration. In turn, virus-mediated down-regulation of 
αCaMKII expression in the NAc shell reduced break points [73]. In the NAc shell, 
αCaMKII binds directly to D3-receptors. This binding is Ca2+-sensitive and can be 
enhanced by autophosphorylation of αCaMKII. Recruitment of αCaMKII to D3 
receptors transiently inhibits receptor efficacy [74] (Table 1). Downstream αCaMKII 
action, reduced D3 receptor function at the level of the NAc was associated with 
enhanced impulsivity and cocaine reinforcement [10], which may facilitate the 
transition to compulsive psychostimulant self-administration [11]. While there is no 
direct evidence that CaMK-dependent drug memories override normal CaMK-
dependent memories, as it would be expected in the time course of addition 
establishment, indirect evidence suggests at least a competition at the level of 
CaMK-induced morphological changes. It was shown that AMPH self-administration, 
which leads to dendritic arborization and an increase in spine density in the 
neocortex and NAc, would prevent morphological changes induced by normal 
learning [75,76]. Whether CaMK-dependent drug memories are stronger than normal 
memories and, therefore, induce a shift in behavioral repertoire from normal to 
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addiction-related behaviors, is currently unclear. Other factors, like the loss of 
impulse control over established drug-related behaviors, are under serotonergic 
control [12], which is, in turn, CaMK dependent [129,132].  
Reinstatement of self-administration: The reinstatement of cocaine seeking by D1-
receptor activation in the NAc shell is mediated by L-type Ca2+-channels and 
subsequent phosphorylation of CaMKII at T286 and of AMPA GluA1- subunits 
(Table 1). Blocking CaMKII in the NAc shell, but not in the basolateral amygdala 
(BLA), attenuates cocaine-induced reinstatement of cocaine-seeking [58,77]. This 
suggests a strong link between dopaminergic and glutamatergic signalling in the 
reinstatement of cocaine-seeking mediated by CaMKII [58]. 
Dopamine activity: The mesocorticolimbic dopamine system plays a crucial role in the 
establishment of psychostimulant abuse-related behaviors [1]. Basal dopamine level 
in the DS of αCaMKII deficient mice are significantly enhanced compared to wild-type 
(WT) mice [65]. This is not due to an altered dopamine synthesis rate or enhanced 
dopamine transporter (DAT) -mediated dopamine uptake [65,78]. However, 
enhanced vesicular dopamine release is found in αCaMKII deficient mice, which may 
explain the enhanced extracellular dopamine levels [65]. 
The AMPH-induced increase in extracellular dopamine levels is markedly reduced in 
striatal synaptosomes, in brain slices, and in-vivo in αCaMKII deficient mice. This is 
in line with findings showing αCaMKII and its T286 autophosphorylation to be 
essential requirements for AMPH-triggered substrate efflux at the DAT [65,78].  
Withdrawal from repeated cocaine- or AMPH treatment sensitized striatal dopamine 
responses to an AMPH challenge in rats. This sensitization could be blocked with the 
rather unspecific CaMKII inhibitor KN-93 [79,80], suggesting a role of CaMKII in 
neurochemical sensitization during chronic psychostimulant exposure. 
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The lack of αCaMKII autophosphorylation enhances basal dopamine levels in the 
NAc and PFC of mice. The cocaine-induced dopamine increase in both brain regions, 
however, is attenuated. Reduced neurotransmitter activation is associated with lower 
c-Fos activation, as an indicator of reduced cellular activation, after cocaine in the 
NAc and hippocampus [67,81]. CaMKII phosphorylates tyrosine hydroxylase (TH), 
the rate limiting enzyme in dopamine synthesis, and the DAT [82,83]. Since TH, DAT, 
CaM, and CaMKII are co-expressed in mesolimbic projections [78,84], it has been 
suggested that dopamine synthesis is regulated by CaMKII-controlled TH activity 
[85]. An increase in basal dopamine levels may, thus, limit the capacity for the drug-
induced dopamine increase. The CaMKII mediated DAT-phosphorylation is 
essential for an AMPH-induced dopamine increase, but not for regulation of basal 
dopamine efflux [78,84]. The DAT is a binding partner of CaMKII in dopaminergic 
neurons. CaMKII has a strong influence on dopaminergic activity. However, there is 
also some feedback, in that D2-, D3-, and D4 receptors regulate CaMKII activity 
[74,86-88]. It should be noted that CaMKs interact also with other neurotransmitter 
systems which are pivotal for drug-related behaviors (Table 1). 
Serotonin activity: In the absence of a dopamine response, rewarding effects of 
psychoactive drugs can be mediated by the serotonergic system [12,83]. The lack of 
αCaMKII autophosphorylation enhanced basal serotonin (5-HT) levels in the NAc and 
PFC of mice. In contrast, the cocaine-induced 5-HT increase in both brain regions 
was abolished in the αCaMKIIT286A mice [67]. Tryptophan hydroxylase 2 (TPH2) is the 
rate-limiting enzyme in the biosynthesis of 5-HT in the brain. Its activity is under the 
control of CaMKII [126]. A lack of αCaMKII autophosphorylation may limit the 
capacity of transmitter available for release into the extracellular space upon 
excitation. This may lead to reduced 5-HT activation, which may account for the 
delay in the establishment of the rewarding effects of cocaine [12,67]. CaMKII binds 
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to serotonin transporters (SERT) in neurons, but with lower affinity than to the DAT. 
Pharmacological inhibition of CaMKII impairs the AMPH-induced SERT efflux, but not 
substrate uptake [127]. While CaMKII has a strong influence on serotonergic activity, 
there is also a feedback regulation of CaMKII activity by 5-HT1A-receptors [128,129]. 
Opioids 
Activation of opioid receptors induces a Ca2+-transient which also activates CaMKs 
[90] (Figure 1). µ-Opioid receptors, which are co-localized with CaMKII in neurons 
[91], are also targets for CaMKII [92] (Table 1). The CaMKII mediated 
phosphorylation of µ-opioid receptors contributes to functional desensitization after 
activation [93]. An acute morphine application enhances autophosphorylation and 
activity of CaMKII in the striatum, hippocampus, and PFC of rats [94-97], without 
affecting CaMKII gene expression [98]. Chronic morphine administration during 
CPP learning increases CaMKII and pCaMKII in the ventral- and dorsal striatum as 
well as in the hippocampus of rats [97,99]. This is paralleled by an increase in 
CaMKII mRNA expression [98]. Chronic morphine treatment increases expression 
of CaMKIV in the CA3 region of the hippocampus of mice, whilst it decreases it in the 
DS and other brain areas [100]. Withdrawal from repeated morphine and heroin 
administration, or naloxone precipitated withdrawal increases CaMKII activity and 
mRNA levels in the hippocampus and medial PFC (mPFC) of rats [94,98,101,102]. 
Heroin withdrawal has no effects on CaMKII or CaMKIV levels in the mPFC [102], 
while CaMKII activity returned to control levels within a week of withdrawal [16]. The 
reinstatement of morphine self-administration by a priming injection of morphine 
induces an increase in T286 p-CaMKII, but not p-CaMKII levels in the NAc shell of 
rats compared to levels during extinction [103]. 
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CPP: The establishment of morphine-induced CPP depends on CaMKII in the brain 
[99]. Pharmacological inhibition of CaMKII in the hippocampus and amygdala blocks 
the establishment and reinstatement of morphine-induced CPP [104]. 
Pharmacological inhibition of CaMKII in the mPFC, but not in the BLA, blocks the 
establishment of morphine- and heroin-induced CPP in naïve rats. In contrast, in 
chronically treated and withdrawn rats, mPFC blockade of CaMKII has no effect on 
CPP-establishment. Intra-BLA pharmacological blockade of CaMKII, however, blocks 
morphine- and heroin CPP-establishment [102,105]. This effect is most evident in the 
late phase of CPP consolidation 12h post conditioning [106]. CaMKIV is required for 
the establishment of morphine-induced CPP in mice, since CaMKIV KO mice show a 
significantly reduced CPP for morphine [107]. 
Self-administration: Inhibition of CaMKII activity in the NAc shell reduces the 
reinstatement of morphine-seeking in rats [70,103]. This effect is potentially mediated 
by a decrease in T286 CaMKII phosphorylation in the NAc [70]. 
Withdrawal and abstinence: Withdrawal from chronic morphine administration 
induces withdrawal symptoms. The development of withdrawal symptoms is blocked 
by intra-hippocampal injection of the unspecific CaMKII inhibitor KN-62 [92]. After 
seven days of morphine treatment, naloxone precipitates withdrawal symptoms, like 
wet-dog shakes, paw tremors, or jumping. There is no difference in these withdrawal 
signs between CaMKIV KO and WT mice, which suggests no role for CaMKIV in 
morphine withdrawal behaviors [107].  
 
Alcohol 
Acute alcohol application does not affect CaMKII activity in astrocytes [108]. In 
contrast, repeated alcohol administration enhances CaMKII activity in neurons and 
astrocytes (Figure 1) [108,109] and increases phosphorylation rate [110]. Free choice 
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alcohol drinking increased protein levels of CaMKII, but not CaMKII in the 
amygdala and NAc of mice [111]. Operant alcohol self-administration increases p-
CaMKII levels in the amygdala without changing total CaMKII levels [111].  
CPP: CPP measures the learning and expression of an association between the 
incentive properties of the drug with environmental cues. Altered CPP may, thus, 
result from changes in learning and memory or/and changes in the rewarding value 
of a drug [47]. αCaMKII autophosphorylation plays a special role in the speed at 
which alcohol induces CPP in mice. Preference for an alcohol-paired environment 
was established after seven conditioning trials in WT mice. Surprisingly, αCaMKII 
autophosphorylation deficient mice (αCaMKIIT286A) establish a profound alcohol CPP 
after only a single alcohol conditioning trial [112]. The disparity between the reported 
establishment of alcohol drinking [113] and CPP [112] may be explained by the acute 
effects of alcohol in the CPP paradigm. CPP involves several learning processes and 
is not simply a result of incentive-driven behaviour [47]. αCaMKIIT286A mice display 
enhanced activity and hyper-arousal in response to potentially threatening 
environments, while showing no altered behaviour in well-habituated environments 
[114]. Arguably, one key component to compulsive drug seeking is the alleviation of a 
negative affective state resulting in negative reinforcement [115]. Alcohol drinking 
behaviour was measured in a familiar home cage environment while CPP rewarding 
effects were measured in a less familiar environment, which might together with the 
injection process represent an aversive/threatening stimulus. This view is supported 
by the observed hyperactivity in αCaMKIIT286A mice during CPP baseline and novel 
open field exposure, but not in familiar home cages [114]. In contrast to WT mice, 
alcohol has an acute and persistent sedating effect in the αCaMKIIT286A mice. One 
possible explanation of this effect is that alcohol alleviated the threat-induced 
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behavioural responses in αCaMKIIT286A mice in a potentially aversive new test 
situation, thus driving CPP learning [47]. 
Self-administration: CaMKII activity and autophosphorylation in the amygdala is 
required for operant alcohol self-administration as local pharmacological inhibition of 
both decreased alcohol-reinforced responding [111]. αCaMKIIT286A mice showed 
initially reduced alcohol drinking in a two-bottle free-choice procedure. This effect is 
persistent until animals are withdrawn and reinstated twice to alcohol [113]. These 
findings suggest that CaMKII autophosphorylation controls the speed at which 
alcohol drinking is established, in a similar way as it may control the establishment of 
non-drug related learning [28]. 
Dopamine activity: There is a significantly reduced dopamine response to alcohol in 
the NAc of αCaMKIIT286A mice [113]. An analysis of the cellular activation of the VTA, 
as an origin of the mesolimbic dopamine projections, revealed an enhanced 
activation after acute and subchronic alcohol exposure in the rostral, but not caudal 
VTA in αCaMKIIT286A mice, which appears to be driven predominantly by GABAergic 
neurons [113]. Also cellular activation after alcohol in the hippocampus is reduced in 
αCaMKIIT286A mice [81]. 
Serotonin activity: The lack of αCaMKII autophosphorylation provoked an alcohol-
induced 5-HT increase in the PFC which was not observed in WT animals [113]. High 
alcohol drinking has been associated with deficiencies in brain 5-HT levels and 
turnover [130]. An induced 5-HT increase, in turn, can reduce alcohol drinking [131]. 
The alcohol-induced 5-HT increases in the PFC of αCaMKIIT286A mice may, therefore, 
contribute to the reduced alcohol drinking seen in these mice. There is a strong link 
between CaMKII and serotonergic function in the brain. CaMKII is required for the 
phosphorylation and activation of TPH, the rate limiting enzyme in the biosynthesis of 
5-HT [126]. Pharmacological inhibition of CaMKII has been shown to increase the 
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firing rate of 5-HT neurons [132]. This supports the view that a reduced CaMKII 
function may increase 5-HT neuronal firing and terminal 5-HT release, which then 
inhibits alcohol consumption. These data may suggest that αCaMKII 
autophosphorylation controls the speed at which an alcohol preference is 
established, but not the capacity to consume alcohol, at least in part, by a 
serotonergic mechanism.  
Nicotine 
Acute subcutaneous administration of nicotine increases activity of CaMKII in the 
VTA, NAc, and amygdala in mice. Nicotine acute effects on CaMKII activity mainly 
depend on 2 acetylcholine receptor subunits, but less on 7 subunits [116]. It was 
also suggested that the nicotine-induced 2 mediated phosphorylation of cAMP 
response-element binding protein (CREB), which is required for the rewarding 
properties of nicotine [117,118], is mediated by CaMKII activation in the VTA and 
NAc [116]. CaMKII appears to play a role in nicotine withdrawal behaviours. 
Pharmacological inhibition of CaMKII reduced somatic nicotine withdrawal signs, but 
enhanced anxiety [119]. 
Concluding remarks 
CaMKs are abundant proteins in the brain. In neurons they are a crucial transducer of 
Ca2+-transients into the activation of a plethora of functional targets involved in acute 
molecular and long-term plastic changes at synapses that are the base for learning 
and memory. Accumulating research has now provided evidence for the view that the 
same CaMKs serve also acute and long-term molecular plasticity that directly 
supports the various types of drug memories. Causal chains are now emerging: 
Many (if not all) addictive drugs increase CaMK activity, foremost that of CaMKII, by 
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either enhanced expression, enhanced phosphorylation, or both. This increase lasts 
during periods of drug intake and is a necessary prerequisite for the learning and 
consolidation of numerous drug-related behaviours. During withdrawal, CaMK activity 
usually declines with some delay, just to rise again during reinstatement of drug-
seeking and consumption. Also this behaviour is facilitated by a boost of CaMK 
activity. Various studies have now identified binding partners and phosphorylation 
targets of CaMKs. These comprise not only glutamatergic receptors. Important 
evidence has now demonstrated an extensive control of dopaminergic and 
serotonergic activity in the mesolimbic system, which are crucial mediators of drug 
reward. CaMK activation of these targets may, thus, provide a large number of 
parallel functional pathways by which a drug-induced Ca2+-transient may control drug 
memory establishment and consolidation and, eventually, pave the way to drug 
addiction. This would suggest CaMKs as excellent pharmacological targets to 
prevent the establishment of drug memories. However, there are obstacles that 
currently limit this possibility. CaMK-dependent drug memories compete with normal 
memories and use the same downstream pathways. Currently, there is no CaMK, 
which is exclusively activated by drugs, but not during normal memory formation. 
One way to circumvent this problem could be the tailoring of CaMK-based 
pharmacotherapies to settings and time points where little normal learning is required 
and where drug memories can specifically activated and pharmacologically 
attenuated (see: Outstanding questions). Another future perspective would be the 
development of subtype specific ligands that can target major CaMKs more 
selectively and spare others that are primarily involved in other behaviours [120].  
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Box 1: Drug memories and related preclinical tests 
Parallel to non-drug related memory systems [121], two major drug-memory 
categories can be distinguished: a declarative drug memory and a non-declarative 
drug memory [5-8]. The declarative drug memory should comprise a semantic 
memory for drug facts and a memory for drug episodes. The semantic memory for 
drugs contains all impersonal facts, rules, and concepts involving drugs, e.g., their 
names, where they come from, recommended doses, what others report about its 
effects, and the social rules of their consumption. The episodic drug memory 
comprises the memories of personally experienced episodes with the drug. It is an 
autobiographical memory on the ‘what’, ‘where’, and ‘when’ of the personal drug 
encounters. This may include memories of subjectively experienced acute drug 
effects, e.g., the mental states the drug induced [9].  
The non-declarative drug memory contains engrams of the classically conditioned 
drug memory, instrumentally conditioned drug memory, habit memory, procedural 
drug memories, and drug priming memories [8]. Classically conditioned drug 
memories may contain all drug effects that refer to the process of Pavlovian 
conditioning. These may include e.g., the sensitization of the acute locomotor effects, 
drug tolerance, partially conditioned place preference, conditioned locomotor activity, 
conditioned emotional and physiological responses, and conditioned withdrawal 
effects. Instrumentally conditioned drug memories comprise engrams established by 
instrumental conditioning. Major behaviours induced by these engrams are drug-
seeking behaviours and drug self-administration. These memories also include drug-
cues which can serve as secondary reinforcers, as in conditioned place preference 
[47], or which can reinstate drug-seeking and drug self-administration behaviour. 
Drug habit memories refer to instrumental behaviour that is no longer goal directed, 
but stimulus controlled and independent from its behavioural consequences. This 
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type of memory plays an important role in the transition from controlled to compulsive 
drug use and addiction. Procedural drug memories comprise all memories for skills 
involved in handling a drug. This may range from its production (e.g., cooking up 
heroin) to the method of self-administration (e.g., snorting cocaine). Drug priming 
memories refer to those engrams whose activation by a small amount of the drug, 
which would not induce major subjective and behavioural effects in drug naïve 
individuals, can induce drug-related behaviour (e.g., reinstate drug seeking, 
conditioned place preference, or self-administration) and subjective effects in 
experienced users. 
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Box 2: CaMKs shaping human memories and drug memories 
Genetic association studies provide evidence for association of CaMKs with memory 
performance in humans. Easton and colleagues [122] provided the first evidence of 
CaMKII involvement in human memory functions by demonstrating an association 
between CAMK2A gene single nucleotide polymorphisms (SNPs) and spatial as well 
as non-spatial working memory in two populations of young healthy subjects. In line 
with the association findings in healthy humans, two other CAMK2A SNPs have been 
recently associated with the risk of Alzheimer’s disease even though in relative small 
samples [123]. 
In a translational effort, postmortem evidence and genetic associations of CaMK 
gene polymorphisms with various drug use- and addiction-related behaviors have 
been found. Increased NAc levels of CaMKII were reported for cocaine-dependent 
humans compared to controls in a postmortem study [52]. Recently, an association 
between the CAMK2A SNP, rs3776823, and the slope time by which severe cocaine 
consumption was established was found in two independent samples of Brazilian and 
Swiss cocaine users [67]. These findings suggest that polymorphisms in the 
CAMK2A gene may contribute to the speed of acquiring a severe level of cocaine 
intake once consumption has commenced. A genetic study with 670 cocaine 
dependent individuals and 726 controls from São Paulo, Brazil, revealed a significant 
association of cocaine abuse with the rs919334 SNP in the CaMKIV gene promotor 
region [68]. 
In agreement with animal data, several associations between SNPs in the human 
CAMK2A gene and alcohol use and dependence were found. Seven SNPs typed 
from the CAMK2A gene were found to be significantly associated with alcohol 
dependence [113]. Notably, the rs10463293 SNP has previously been associated 
with working memory performance [122], while SNP rs3756577 has been suggested 
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before to influence the risk for Alzheimer’s disease [123]. A set of 13 CAMK2A SNPs 
were found to predict the number of alcohol drinking days per month in a sample of 
adults living in the US [124]. The SNP with the lowest p-value (rs7711562) was also 
significantly associated with alcohol dependence in the study by Easton et al. [113]. 
While emerging evidence revealed an important role of CaMKs in drug use behavior 
and addiction, it also showed crucial involvement in other psychiatric disorders which 
are frequently co-morbid with drug addiction [125]. These findings suggest a 
significant overlap between CaMK genetic mechanisms controlling normal learning 
and memory and those involved in drug memories in humans. 
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Glossary:  
Behavioural paradigms to test drug use and addiction behaviours 
Drug use and subsume numerous distinct behaviours. These behaviours can be 
investigated separately in animal models. The most important of them have been 
used to discover the role of CaMKs. 
Locomotor sensitization: measures the progressive augmentation of the 
hyperlocomotor effects. Sensitization can be context dependent involving a classical 
conditioning or context independent which is assumed not to result from a learning 
process, but from a sensitization of neuronal circuits in the brain to the drug. The 
establishment and expression of sensitization is part of psychoactive drug addiction 
[7,8].    
Conditioned place preference: measures the incentive properties of a drug by its 
conditioning to a spatial context (place in a box). Thereby, an increase in the time 
spend in a previously drug-paired environment indicates incentive properties of a 
drug. CPP learning and expression can be tested separately and involves both, 
classical and instrumental conditioning [47].     
Self-administration: measures if and at which work load (e.g. bar pressing) animals 
learn to self-administer a drug. The route of self-administration differs between drugs, 
e.g. oral for alcohol and i.v. by an implanted catheter for other drugs. Rapid learning 
and a high motivation to work for the drug indicate strong reinforcing effects of the 
drug and, thus, a high potential for addiction. It is believed that instrumental 
conditioning is the major learning mechanism for operant drug self-administration 
[7,8]. 
Reinstatement of self-administration: measures the ability of a stimulus that was 
paired with the availability of the drug, to reinstate self-administration behaviour after 
a period when the drug was not available and the behaviour extinguished. Such a 
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stimulus can be sensory (e.g. a cue) or intrinsic (the effects of the drug itself). 
Reinstatement is believed to model in particular relapse behaviour [7,8]. 
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Open questions 
 Most research revealed an important facilitating role for CaMKII in drug memory
establishment. CaMKIV rather appears a resilience mechanism. What is the role of
other CaMKs, such as CaMKI and CaMKK, in drug memories?
 CaMKII is a crucial mediator of LTP, which has been shown to be an important
mechanism in normal learning. Does CaMKII also drive drug-induced LTP and is
this LTP a necessary condition for distinct types of drug memories to be
established?
 There is a dissociation in CaMKII activation between brain areas during different
stages of the drug taking time line. Most evidence suggests the VTA and NAc shell
as a crucial anatomical locus for drug memories. However, is there a functional
impact of drug-induced CaMK activity changes in other brain areas, such as the
hippocampus, amygdala, or PFC?
 Currently available CaMKII inhibitors are not specific for CaMKII. They also block
other CaMKs and other molecules. However, many of the mechanistic findings rely
on these inhibitors. Can findings be confirmed with more specific inhibitors?
 Research has focused mostly on cocaine, amphetamine, morphine, heroin, and
alcohol. Do emerging principles of e.g., CaMKII action also apply for other widely
abused drugs, such as cannabis, -hydroxybutyrate, methamphetamine, or
halluzinogenic drugs?
 The strong overlap in the function of CaMKs between normal learning and memory
and drug memories makes it difficult to use them as plain pharmacological targets.
However, would there be time windows, e.g., in therapeutic settings, when
selective inhibition/stimulation of CaMKs could be beneficial for addiction therapy?
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Figure legends 
Figure 1 CaMKII activity during long-term repeated exposure to major addictive 
drugs and its functional consequences. A). Psychostimulants like cocaine or 
amphetamine increase activity of CaMKII in the nucleus accumbens (Ncl. acc.) 
shell of the brain after acute and chronic psychostimulant administration (red arrows 
= single drug episodes). Thereby, an increase in CaMKII activity can be induced by 
enhanced phosphorylation and/or expression. The activity increase is paralleled by 
phosphorylation of various targets, such as AMPA receptor GluA1 subunits, 
extracellular signal-regulated kinase-1, CREB and many more [48,49]. Interestingly, 
GluA1 Ser831-phosphorylation is one of the prerequisites for appetitive incentive 
learning [133]. Altogether, this appears to facilitate the establishment and expression 
of numerous drug-related behaviours (↑). After cessation of drug administration, 
CaMKII activity declines to basal levels. During reinstatement of drug self-
administration, however, it is increased again. Importantly, the action of CaMKII 
appears brain area specific, no such response or facilitation of behaviour was found 
e.g., in the nucleus accumbens core. B.) Opioid drugs like morphine or heroin 
increase the activity of CaMKII in the hippocampus and nucleus accumbens/ shell 
of the brain after chronic drug administration. This increase appears to facilitate the 
establishment of the rewarding effects of the drugs. After cessation of drug 
administration, CaMKII activity remains elevated before it eventually declines to 
basal levels. This elevation was shown to contribute to the expression of withdrawal 
symptoms. During reinstatement of drug self-administration CaMKII activity is 
increased again, which is required for this drug-related behaviour. Importantly, the 
action of CaMKII appears brain area specific, no such response or facilitation of 
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behaviour was found e.g., in the nucleus accumbens core. C.) Alcohol increases the 
activity of CaMKII in the amygdala and nucleus accumbens after chronic drug 
administration. Alcohol drinking also increased Ser831-phosphorylation of AMPA 
GluA1 subunits, which are co-expressed with CaMKII in neurons [104]. These 
effects appear to facilitate the establishment of some drug-related behaviours (↑), but 
may also limit other behaviours (↓). CaMKII activity during withdrawal and 
reinstatement and its contribution to alcohol-related behaviours at these time points is 
currently unclear and awaits further investigation.  
Table 1 Major binding partners and phosphorylation targets of CaMKII in the brain 
(↑ enhanced function, ↓ reduced function, -- no effect on function; * targeted by 
CaMKII; AMPH - amphetamine, DA – dopamine).  
transmitter system   target   target function   phosphorylation site   effect on function   references 
 glutamate 
 GluR1    AMPA receptor subunit   Ser831  ↑  134‐139 
 NR2B   NMDA receptor subunit   Ser1303  ↑   140,141 
 dopamine 
 tyrosine hydroxylase    dopamine synthesis ↑   142‐144 
 dopamine transporter   dopamine clearance    N terminal serines*  ↑ (AMPH‐induced DA efflux)   65,78,85 
 D3 receptor   dopamine receptor   3rd intracellular loop*  ↓   74 
 serotonin 
 tryptophan 
hydroxylase 2   serotonin synthesis   Ser19  ↑   145,146 
 serotonin transporter    serotonin clearance    N terminal serines*  
↑ (AMPH‐induced 5‐HT 
efflux) 
‐‐‐ (substrate uptake) 
 127 
endogenous opioides   µ‐opiate receptor   opiate receptor   Ser261 and Ser266  ↑ desensitization   147‐149  
 GABA   GABAA receptor   GABA receptor   b2 subunit  ↑  150 
 general  
 L‐type Ca2+ channel    Ca2+ channel   ↑   151 
 BK channel   high conductance  
 Ca2+ activated  
 voltage gated K+ channel 
 Thr107  ↑   152 
↓  153 
SynGAP  Ras‐GTPase activating protein  ↓   154 
 FosB   transcription factor   Ser27*  ↑   52 
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